logo

Exhibiting at VIV Asia 2025

3-4977
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Veterinary Raw Materials: Nicarbazine, Sulfachloropyridazine Sodium, Florfenicol

Feed Additives: Vitamin Additives for Poultry and Livestock

Veterinary Pharmaceuticals: Oxytetracycline Injection 20%, Ivermectin Injection 1%, Ofloxacin Soluble Powder 10%

Zhengzhou Fuyuan Animal Pharmaceutical Co., Ltd., headquartered in Zhengzhou, Henan Province, China, is a specialized manufacturer of veterinary pharmaceutical products, feed additives, and active pharmaceutical ingredients (APIs) for animal health. With over two decades of industry presence, Fuyuan has established a reputation for quality, research-driven production, and compliance in domestic and international animal health markets.

Core Business and Offerings

Fuyuan’s operations are vertically integrated across R&D, manufacturing, and sales of veterinary products. Its primary product categories include:

  • Veterinary Raw Materials (APIs)

    • Nicarbazine
    • Sulfachloropyridazine Sodium
    • Florfenicol
  • Feed Additives

    • Vitamin A, D3, E combinations
    • Premixes tailored for poultry, swine, and ruminants
    • Functional additives supporting immune function and growth
  • Veterinary Pharmaceuticals

    • Oxytetracycline Injection 20%
    • Ivermectin Injection 1%
    • Ofloxacin Soluble Powder 10%
    • Multivitamin oral liquids and injectable supplements

Fuyuan's diversified portfolio supports both prevention and treatment of a wide range of livestock diseases while promoting performance optimization in animal husbandry systems.

Specialisation and Core USP

Fuyuan’s key strengths are rooted in:

  • Specialization in ionophore anticoccidials and broad-spectrum antibiotics for veterinary use
  • Advanced formulation technologies including injectables, soluble powders, and oral liquids
  • Dedicated R&D center focused on developing innovative formulations and improving bioavailability
  • Full regulatory documentation and COA support for global markets

Their high-volume production lines offer cost-effective solutions that meet stringent quality benchmarks, making Fuyuan a preferred OEM partner.

Global Market Presence

Fuyuan exports to over 30 countries, with significant markets in:

  • Southeast Asia: Vietnam, Philippines, Indonesia
  • Middle East and North Africa: Egypt, Iran, Jordan
  • Latin America: Peru, Ecuador
  • Sub-Saharan Africa: Nigeria, Ethiopia, Kenya

The company partners with veterinary distributors, feed manufacturers, and government animal health programs in several of these countries.

Trade and Shipment Data

According to third-party trade sources such as Volza and ImportYeti:

  • Zhengzhou Fuyuan has completed over 95 export shipments between 2021–2024
  • Primary exported products include Ivermectin Injection, Florfenicol API, and Oxytetracycline
  • Estimated annual export value exceeds USD 3.2 million
  • Key clients include national veterinary product importers and contract formulation companies

Manufacturing and Technical Capabilities

Fuyuan operates GMP-certified production facilities equipped with:

  • Sterile injectable production lines
  • Powder blending and packaging systems
  • Liquid preparation and bottling units
  • In-house microbiology and chemistry labs for quality control

Annual production capacities:

  • Over 50 million vials of injectables
  • More than 1,000 tons of veterinary-grade APIs
  • Custom formulations based on client registration dossiers

The company maintains a strong focus on R&D investment, employing experienced veterinarians, pharmacologists, and chemists.

Certifications and Quality Assurance

Fuyuan adheres to strict quality and regulatory standards, including:

  • GMP (Good Manufacturing Practice) certification for veterinary drugs
  • ISO 9001:2015 Quality Management System
  • Adherence to China MOA (Ministry of Agriculture) guidelines
  • Full batch traceability and release testing
  • COA, MSDS, TDS, and stability data provided with shipments

The company supports clients with regulatory registration documentation for new market entries.

Major Achievements

  • Registered Ivermectin Injection and Florfenicol API in over 15 countries
  • Developed a proprietary high-purity Nicarbazine API used across multiple premix brands
  • Collaborated with national livestock agencies for mass animal treatment programs in Asia and Africa
  • Recognized as a Top 10 Exporter of Veterinary APIs in Henan Province
  • Regular exhibitor at VIV China and CPhI Global

Zhengzhou Fuyuan Animal Pharmaceutical Co., Ltd. continues to drive value in the global animal health sector through affordable, high-quality veterinary medicines and feed additives, built on technical innovation and manufacturing integrity.